The definitive forum for industry leaders shaping the future of life sciences patent litigation. From Hatch-Waxman and BPCIA disputes to skinny labels and ANDA strategies, this event equips you with practical takeaways to stay ahead of evolving patent trends and recent rulings. Covering PTAB strategy, venue selection, and early-stage decision-making, our agenda focuses on how recent decisions and procedural shifts are influencing real-world outcomes in high-stakes pharma and biotech disputes for innovators, generics, biosimilars, and biotechs alike.